About JAMA Dermatology
Kanade Shinkai, MD, PhD
Editor
JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery. JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Journal Frequency and Access. JAMA Dermatology is published online weekly, every Wednesday, and in 12 print/online issues a year. The journal receives over 5 million online visits annually and more than 5.1 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Editorial Information. The journal’s acceptance rate is 9%. The median time to first decision is 5 days, and 42 days with review. The journal's Impact Factor is 10.3, one of the highest ranking among dermatology journals. All articles are published online first. Additional information on the types of articles published and editorial policies is available in the journal's Instructions for Authors.
Editorial Team. Kanade Shinkai, MD, PhD, UCSF Department of Dermatology, San Francisco, California, is the editor in chief. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.
Mission Statement: JAMA Dermatology publishes information concerning the skin, its diseases, and their treatment. Its mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders. This journal has a particular interest in publishing clinical and laboratory studies that reveal new information pertinent to the interests and needs of the medical dermatologist, dermatologic surgeon, and all those concerned with state-of-the-art care of cutaneous disease. We believe that knowledge derived from well-designed clinical trials and studies of cost-effectiveness are especially important for improving the practice of dermatology. Studies that increase the understanding of the outcome of treatment or the means by which the burden of dermatologic disease can be measured and reduced to promote the health of patients with skin disease will receive special priority. The journal regularly publishes reports on clinical investigations, editorials, and systematic reviews with meta-analyses. It also features reports and discussions on clinicopathologic correlations; clinical disorders of unique didactic value; pharmacologic, medical, and surgical therapeutics; and ethical, moral, socioeconomic, and political issues.
JAMA Dermatology
ISSN 2168-6068 (Print)
ISSN 2168-6084 (Online)
Back to top
Why Publish in JAMA Dermatology?
JAMA Dermatology publishes innovative, clinically relevant research that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery.
Impact and Reach
- Impact Factor of 10.3, one of the highest ranking among dermatology journals
- Over 5 million annual visits to the JAMA Dermatology website; more than 5.1 million article views and downloads
- International authors: 55% of submissions come from outside the United States
- Extensive press coverage, with over 4,500 media mentions in 2021 in outlets such as Forbes, NBC News, and ABC News
- Top Altmetric scores—JAMA Dermatology published 26 of the top 50 articles among dermatology journals, including the No. 1 article
- Number of citations, Altmetric score, page views, and PDF downloads tracked for your published article
- Broad reach through related commentary, author audio interviews, podcasts, email alerts, social media, multimedia, and more than 56,000 followers on Twitter and Facebook
Prompt Decisions and Rapid Publication Timelines
- Highly selective peer review and editorial evaluation, with 9% acceptance rate for all submissions
- Median time to first decision: 5 days without external peer review; 42 days with review
- Online First publication of all articles
- Coordination with meeting presentation: Opportunity to publish new research simultaneously with your presentation
Author Service
- User-friendly manuscript submission system and process
- Prompt, expert review and consideration from our experienced editors
- Highest standards followed to improve your accepted manuscript's accuracy, reliability, and readability
- CME credit available for lead authors who publish in JAMA Dermatology
- Opportunity for your work to be augmented with expert illustration, interactive features, video, audio, and visual abstract
- Free public access: All research articles are free 12 months after publication on the journal's website
- Open access: Authors of research articles may elect to pay for immediate open access on the day of publication
- Direct deposit to PubMed Central: All research articles deposited directly in PubMed Central (PMC) for authors
- Online extras: Ability to post supplemental content online and download your article's tables and figures as PowerPoint slides
- The JAMA Network advantage: Authors of papers not accepted by JAMA Dermatology may have the option to have their papers and reviewers' comments automatically referred to one of the JAMA Network specialty journals and/or JAMA Network Open
- Dedicated media team to promote your article to the news media and on social media
JAMA Network journals welcome manuscript submissions on diversity, equity, and inclusion. For example, see the Health Disparities Topic Collection and the list of articles on race, racism, and racial/ethnic disparities/inequities published during the last 5 years here.
For more information, see JAMA Dermatology Instructions for Authors. Submit your manuscript at https://manuscripts.jamaderm.com.
Back to top
Updated June 2022